Loading…
Loading…
Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.
DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine and workforce health services, today announced that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president and chief financial officer, effective Nov. 1, 2026. Newton will continue to report to Matt DiCanio, Concentra's president and chief financial officer, who will become president and chief executive officer on Nov. 1, 2026. Newton will lead Concent.
Concentra Group, QuinStreet and Arrow Electronics pair broker rating upgrades with strong projected earnings growth, making them stocks to consider.
Amarantus Bioscience (OTCMKTS:AMBS - Get Free Report) and Concentra Group Holdings Parent (NYSE: CON - Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Valuation and Earnings This table compares
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.
Concentra (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, M
DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer, effective Jan. 1, 2027. Returning to the organization where she previously served in physician leadership roles, including area medical director, Dr. Rosenthal will lead Concentra's national clinical strategy, physician leadership,.